Exoskeleton Robots Segment to Dominate North America Rehabilitation Robots Market during 2020–2028   

According to a new market research study on “North America Rehabilitation Robots Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type and End User” is expected to reach US$ 1,674.90 million by 2028 from 408.99 US$ million in 2021. The market is estimated to grow at a CAGR of 22.3% from 2021 to 2028. The report provides trends prevailing in the North America rehabilitation robots market along with the drivers and restraints pertaining to the market growth. Growth in geriatric population, stroke, and rehabilitation therapy with the help of robots is the major factor driving the growth of the North America rehabilitation robots market. However, issues associated with expensive devices hinders the growth of the North America rehabilitation robots market.

The North America rehabilitation robots market is segmented into type and end user. Based on type, the rehabilitation robots market is segmented into therapeutic robots, assistive robots, exoskeleton robots, and prosthetic robots. The exoskeleton robots segment held the largest share of the market in 2020. Based on end-user, the rehabilitation robots market is segmented into hospitals, rehabilitation centers, and specialty clinics. The rehabilitation centers segment held the largest share of the market in 2020.

The North American region is highly affected due to the outbreak of the Covid-19 pandemic. Countries such as the US and Canada reported the most significant numbers of COVID-19 positive cases. The US registered the highest number of deaths due to the COVID-19 pandemic. The chaotic situation was created in the medical industry across the countries, increased demand for COVID diagnostics and therapeutics have dramatically increased in the hospitals. In the US, due to an increasing number of infected patients, healthcare professionals and leading organizations distract the flow of healthcare resources from research & development to primary care, which slows down the process of innovation. In addition to the physical or cognitive state, psychological health acts as an indicator of the surviving population's quality of living. Nevertheless, considering the rapid spread of COVID-19, several healthcare services are looking for strategies to promote physical distancing and enhance healthcare procedures. Physical distancing and isolation measures are adopted worldwide. The supply schedule and distribution channel have also been disrupted during these months, and manufacturers are facing many backorders on many products. Therefore, it is likely to slight negative affect on the rehabilitation robot market due to the abovementioned points. In addition, the COVID-19 pandemic is perplexing healthcare institutions in the region with unprecedented operational and clinical challenges. Moreover, the shift of priorities from rehabilitation robots to coronavirus diagnosis and treatment devices are leading to a decline in robots manufacturing systems.

Bionik; Cyberdyne Inc.; DIH Medical; Ekso Bionics Holdings Inc; Kinova Inc; Myomo Inc; Rewalk Robotics Ltd; Rex Bionics Ltd; and Toyota Motor Corporation are among the leading companies in the North America rehabilitation robots market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, CYBERDYNE Inc. obtained medical device approval from Singapore Health Science Authority for its product, Medical HAL.

The report segments the North America Rehabilitation Robots Market follows:

North America Rehabilitation Robots Market – By Type

• Exoskeleton Robots
• Therapeutic Robots
• Assistive Robots
• Prosthetic Robots

North America Rehabilitation Robots Market – By End User

• Rehabilitation Centers
• Hospitals
• Specialty Clinics

North America Rehabilitation Robots Market – By Country  

• US
• Canada
• Mexico